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coronary total occlusion. However, despite improving techniques
for opening chronic total occlusions, the benefit of successful
recanalization of the artery remains unclear.
Objectives: The purpose of this study was to know the clinical
characteristics and angiographic outcome of patients undergoing
percutaneous coronary intervention in coronary total occlusion.
Methods: Consecutive patients undergoing nonurgent coronary
angiography with CTO were prospectively identified from January
2013 to June 2014. Coronary total occlusion was defined as
thrombolysis in Myocardial Infarction flow grade 0 and duration
>3 months. Detailed baseline clinical, angiographic, electrocar-
diographic, and revascularization data were collected and
compared successful versus failed procedures.
Results: Coronary total occlusions were identified in 76 patients
and procedural success was seen in 83% patients (63 0f 76). Ma-
jority of pts weremale (80.95% vs 69.23) and in the age group of 51-
60 yrs (46.03 % vs 30.76%). Chest pain (50.0 % vs 44.82%) and dys-
pnea (30.0 % vs 34.4%) were predominant symptoms. Most pa-
tients had USA (55.55 % vs 76.9%) and normal LV function was
seen in 57.1 % vs 12.69 %. Most coronary total occlusion were
located in LAD (38.09% vs 61.53%) & RCA (39.68 vs 38.46%). Fluo-
roscopic time (35.9 min vs 40.min) & contrast (165 ml vs 180 ml)
used were more with failed procedures. 67% of pts received siro-
limus DES. Three patients in failed procedure had perforation and
tamponade requiring emergency surgery. At one year follow up 5
pts (7.69 %) in successful group had restenosis requiring repeat PCI
(4.7%) & CABG (3.17%).
Conclusions: Patients with successful recanalization of CTO with
PCI have better symptom relief, better clinical outcome, improved
left ventricular function and better long-term survival compared
with patients in whom the attempt to re-canalize CTO has failed.
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Background: Bioresorbable Vascular Scaffolds (BVS) has many
potential advantages over the current drug eluting stents (DES).
Their non inferiority against DES in type A lesions was shown in
the ABSORB I trial. We wanted to present our experience with BVS
in real world type C lesions.
Aims: To present the immediate procedural outcomes and the
intermediate term outcomes of BVS in type C lesions and to
describe the technical considerations of optimal deployment of
BVS in these types of complex lesions.
Methods: We collected the data of all consecutive patients who
underwent BVS at our centre from January 2013 to June 2014. The
complexity of the lesion was scaled using the ACC/AHA criteria.
All patients were preloaded with clopidogrel 300 mg or prasugrel
60 mg or ticagrelor 180 mg along with aspirin and were main-
tained on dual anti-platelet therapy for one year after the proce-
dure. Clinical follow up for major adverse cardiovascular events
were collected (death, non fatal MI, target vessel or lesion
revascularisation).
Results: During the study period we have used 62 BVS in 52 pa-
tients out of which 18 were in type C lesions. Seven for Ostial le-
sions (3 aorto ostial and four non aorto ostial), three for chronic
total occlusion (CTO) including one graft CTO, six for long lesions
> 30 mm that required overlapping scaffolds (14 scaffolds were
used in these six patients with an average of 44 mm of BVS per
patient) and two for bifurcation lesions in which the side branch
closed requiring additional intervention (rescued with a DES in
one case and BVS in the second case). OCT guidance was used in
14 out of the 18 cases and both IVUS & OCT was used in one pa-
tient. One patient had a re-stenosis requiring balloon dilatation at
6 months of follow-up.
Conclusion: BVS for type C lesions is feasible with excellent pro-
cedural and intermediate term outcomes. These results are from a
single centre and needs to be proven in large multicentre studies
with longer follow up. Technically the procedure is demanding as
it is bulkier, radiolucent & requires intra coronary imaging to
optimize the results.
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Background: Revascularisation of proximal left anterior
descending coronary artery (LAD) has remained matter of debate
since long. Data have shownmore re stenosis in the proximal LAD
as compared to non proximal LAD. However, with availability of
2nd generation stents, this gap seems to have reduced. In the
present study, we compared outcomes of percutaneous coronary
intervention (PCI) on proximal LAD versus non-proximal LAD.
Method: Of the 958 patients who underwent PCI by single operator
during January 2003 to 2010, 351 patients were included for the
analysis after excluding non LAD Percutaneous coronary inter-
vention (PCI) patients who were lost to follow up. Baseline char-
acteristics and in-hospital outcomes were compared in 83
patients with PCI on proximal LAD versus 268 patients with PCI on
non-proximal LAD. Long-term PCI outcomes were also compared
between these groups. The statistical methods included Chi-
square test, Fisher's exact test, student's t-test, kaplan-meier
analysis and multivariate regression model.
Results: Both groups had similar baseline characteristics. Among
the angiographic and procedural characteristics, pre-dilatation
and post dilatation done significantly higher in non- proximal LAD
group (p<0.0001, p<0.02 respectively). Drug eluting stents were
more used in LAD proximal group (p< 0.0002) and also had larger
stent diameter (p<0.04).) There were no significant difference in 30
days mortality between the groups (p¼0.98). However, In long-
term follow-up, major adverse cardiac events [(MACE), death,
myocardial infarction, stroke, and repeat procedures] were
significantly higher in LAD proximal groups (p<0.02). Freedom
from new revascularisation procedures (Proximal LAD 91.6% Vs
non proximal LAD 98.1%, p ¼ 0.0002) and frequency of repeat
hospitalization (Proximal LAD 13.3% Vs non proximal LAD 2.2%,
p ¼ 0.003) were also superior in the non proximal LAD group.
Conclusion: In our study, there was no difference in the short-
term clinical outcomes (MACE and its components) of LAD prox-
imal and LAD non proximal PCI. However, long term outcomes
were superior in LAD non proximal group.
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